Drug Development and Discovery
Employing innovative solutions to accelerate drug discovery and development
Employing innovative solutions to accelerate drug discovery and development
Zenovel is dedicated to enhancing drug development and discovery by offering advanced solutions, addressing challenges, and bringing therapeutic ideas to fruition.
Drug research and discovery is an intricate field that involves knowledge, creativity, and accuracy. From original research to clinical development, Zenovel offers comprehensive services for every stage of the drug development process. Our comprehensive strategy guarantees that your medication/ drug candidates satisfy the highest requirements for efficacy, safety, and quality, and are optimised for success. We provide advanced drug development and discovery services, utilizing advanced technologies and a team of experienced scientists, to expedite the development of drug candidates, providing insights and support for innovative therapies.
Zenovel’s Chemistry Services provide comprehensive support in medicinal and synthetic
chemistry, enabling the development of innovative therapeutics from concept to clinic, leveraging the expertise and resources required for drug discovery and development.
Our team, comprising experts in chemistry, biology, pharmacology, and regulatory affairs, offers comprehensive support for drug development projects.
We utilize the latest technologies and methodologies to enhance innovation and efficiency in drug discovery and development.
Works closely with clients to create conducive environment that enhances project success and expedites development timelines.
We guarantee the highest quality and regulatory compliance, ensuring your products meet all safety and efficacy guidelines.
We offer tailored services to meet the unique needs of your projects, ensuring that your drug candidates are optimized for success.
Risk-Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data, and
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is the
Lipinski’s Rule of 5 (Ro5) is a crucial guideline in pharmaceutical development, helping researchers evaluate a compound’s likelihood of becoming an effective oral drug. However, with the rapid evolution of therapeutic strategies, it’s worth considering the relevance of Ro5 in the current drug design landscape. Understanding Lipinski’s Rule of 5
Regulatory affairs (RA) play a crucial role in the pharmaceutical industry; ensuring products meet quality, safety, and efficacy. As the industry grow further the need for qualified professionals to bridge gaps between companies and regulators increases. This blog explores Zenovel regulatory affairs expertise, our various facets, and valuable contribution to
Navigating the world of pharmaceuticals, medical devices, and biotechnology is never straightforward. With the diversity of regulatory compliance governs the Code of Federal Regulations (CFR) – a regulatory path that shapes companies’ efforts and implements how companies long for their products to be developed, manufactured, and marketed. For companies trying
